Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRA | P10827 | 12/20 | 0.51 |
| ▸ | THRB | P10828 | 12/20 | 0.51 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.48 |
| ▸ | RARB | P10826 | 5/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | RARA | P10276 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | MTOR | P42345 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL3854822 | 0.99 | THRA (0.50) | THRATHRBHAO1RARBMEN1 | |
| Hydrochloric Acid SCHEMBL9662432 | 0.77 | THRA (0.50) | THRATHRBHAO1RARBALDH1A1 | |
| SCHEMBL6936037 | 0.76 | GSK3B (0.44) | MEN1ALDH1A1MAPTKMT2A | |
| Hydrochloric Acid SCHEMBL3847435 | 0.75 | HDAC3 (0.41) | MEN1ALDH1A1MAPTKMT2A | |
| Bromide SCHEMBL3847332 | 0.75 | HDAC3 (0.41) | MEN1ALDH1A1MAPTKMT2A | |
| Bromide SCHEMBL2947798 | 0.75 | RAB9A (0.46) | HAO1ALDH1A1MAPTKMT2A | |
| Bromide SCHEMBL3847336 | 0.75 | NPC1 (0.42) | MEN1ALDH1A1KMT2A | |
| Iodide SCHEMBL10526799 | 0.73 | THRA (0.46) | THRATHRBHAO1RARBALDH1A1 | |
| SCHEMBL7137148 | 0.72 | THRA (0.72) | THRATHRBHAO1RARBMEN1 | |
| SCHEMBL10883866 | 0.71 | THRA (0.75) | THRATHRBHAO1RARBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0808163-B1 | USE OF THIAZOLIUM COMPOUNDS FOR PREVENTING AND REVERSING THE FORMATION OF ADVANCED GLYCOSYLATION ENDPRODUCTS | ALTEON INC (US) | 2003-07-23 | — | — | EP | claimed |
| US-6007865-A | FOR INHIBITING AND REVERSING NONENZYMATIC CROSS-LINKING (PROTEIN AGING), TREATING KIDNEY DAMAGE AND TREATING COMPLICATIONS OF DIABETES, PREVENTING FOOD SPOILAGE | ALTEON INC. | 1999-12-28 | — | — | US | claimed |